VEGFR2 anticorps (Kinase insert Domain Receptor (A Type III Receptor tyrosine Kinase)) (pTyr951)

Details for Product anti-KDR Antibody No. ABIN2687867
Antigène
  • CD309
  • FLK1
  • VEGFR
  • VEGFR2
  • 6130401C07
  • Flk-1
  • Flk1
  • Krd-1
  • Ly73
  • VEGFR-2
  • sVEGFR-2
  • Vegfr-2
  • FLK-1
  • flk-1
  • vegfr-2
  • KDR
  • FLK/KDR
  • flk1
  • flk1b
  • kdrb
  • si:busm1-205d10.1
  • si:ch211-254j6.1
  • si:ch211-278f21.4
  • wu:fc31a09
  • fk52c05
  • flk
  • kdr
  • kdra
  • vegfr2
  • vegfr4
  • vegr2
  • wu:fk52c05
  • kinase insert domain receptor
  • kinase insert domain protein receptor
  • vascular endothelial growth factor receptor kdr-like
  • kinase insert domain receptor (a type III receptor tyrosine kinase)
  • kinase insert domain receptor like
  • KDR
  • Kdr
  • LOC100136647
  • kdr
  • kdrl
Épitope
pTyr951
66
61
49
49
29
23
19
18
16
16
15
14
13
10
9
9
8
7
7
7
7
7
7
6
6
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Reactivité
Humain, Souris
599
356
213
27
7
5
5
4
4
2
2
2
2
2
2
2
2
2
2
1
1
1
1
Hôte
Lapin
562
118
21
2
2
1
1
1
Clonalité
Monoclonal
Conjugué
Cet anticorp VEGFR2 est non-conjugé
44
26
25
22
14
12
10
10
10
10
10
10
3
3
3
3
3
3
3
2
2
2
2
1
1
Application
Immunohistochemistry (IHC), Western Blotting (WB)
460
265
247
142
118
103
31
31
26
24
22
19
16
8
8
4
2
1
Options
Immunogène The antiserum was produced against synthesized phosphopeptide derived from human VEGFR2 around the phosphorylation site of tyrosine 951 (K-D-YP-V-G).
Specificité VEGFR2 (phospho-Tyr951) antibody detects endogenous levels of VEGFR2 only when phosphorylated at tyrosine 951.
Purification The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatogramphy using non-phosphopeptide corresponding to the phosphorylation site.
Plasmids, Primers & others Plasmids, Primers & others VEGFR2 products on genomics-online (e.g. as negative or positive controls)
Antigène
Autre désignation VEGFR2
Pathways Signalisation RTK, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Indications d'application WB: 1:500~1:1000 IHC: 1:50~1:100
Restrictions For Research Use only
Format Liquid
Concentration 1 μg/μL
Buffer phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
Agent conservateur Sodium azide
Précaution d'utilisation This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock 4 °C,-20 °C
Avez-vous cherché autre chose?